Annual CFI
$239.25 M
+$501.39 M+191.27%
31 December 2023
Summary:
Cytokinetics Incorporated annual cash flow from investing activities is currently $239.25 million, with the most recent change of +$501.39 million (+191.27%) on 31 December 2023. During the last 3 years, it has risen by +$435.77 million (+221.75%). CYTK annual CFI is now at all-time high.CYTK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$45.05 M
+$606.50 M+93.09%
30 September 2024
Summary:
Cytokinetics Incorporated quarterly cash flow from investing activities is currently -$45.05 million, with the most recent change of +$606.50 million (+93.09%) on 30 September 2024. Over the past year, it has dropped by -$118.09 million (-161.68%). CYTK quarterly CFI is now -127.22% below its all-time high of $165.50 million, reached on 31 March 2023.CYTK Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$745.37 M
-$118.09 M-18.83%
30 September 2024
Summary:
Cytokinetics Incorporated TTM cash flow from investing activities is currently -$745.37 million, with the most recent change of -$118.09 million (-18.83%) on 30 September 2024. Over the past year, it has dropped by -$1.10 billion (-313.02%). CYTK TTM CFI is now -313.02% below its all-time high of $349.91 million, reached on 30 September 2023.CYTK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTK Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +191.3% | -161.7% | -313.0% |
| 3 y3 years | +221.8% | +78.4% | -102.2% |
| 5 y5 years | +4561.1% | -429.3% | -1406.1% |
CYTK Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +191.3% | -127.2% | +93.1% | -313.0% | at low |
| 5 y | 5 years | at high | +191.3% | -127.2% | +93.1% | -313.0% | at low |
| alltime | all time | at high | +191.3% | -127.2% | +93.1% | -313.0% | at low |
Cytokinetics Incorporated Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$45.05 M(-93.1%) | -$745.37 M(+18.8%) |
| June 2024 | - | -$651.55 M(-2096.1%) | -$627.28 M(-689.6%) |
| Mar 2024 | - | $32.64 M(-140.1%) | $106.40 M(-55.5%) |
| Dec 2023 | $239.25 M(-191.3%) | -$81.41 M(-211.5%) | $239.25 M(-31.6%) |
| Sept 2023 | - | $73.04 M(-11.1%) | $349.91 M(-2357.8%) |
| June 2023 | - | $82.13 M(-50.4%) | -$15.50 M(-52.1%) |
| Mar 2023 | - | $165.50 M(+465.8%) | -$32.36 M(-87.7%) |
| Dec 2022 | -$262.13 M(+77.4%) | $29.25 M(-110.0%) | -$262.13 M(+7.4%) |
| Sept 2022 | - | -$292.37 M(-548.0%) | -$244.05 M(+52.2%) |
| June 2022 | - | $65.27 M(-201.5%) | -$160.39 M(-22.4%) |
| Mar 2022 | - | -$64.28 M(-235.8%) | -$206.78 M(+39.9%) |
| Dec 2021 | -$147.78 M(-24.8%) | $47.34 M(-122.7%) | -$147.78 M(-59.9%) |
| Sept 2021 | - | -$208.72 M(-1205.4%) | -$368.73 M(+41.3%) |
| June 2021 | - | $18.88 M(-457.9%) | -$261.04 M(+6.4%) |
| Mar 2021 | - | -$5.28 M(-97.0%) | -$245.28 M(+24.8%) |
| Dec 2020 | -$196.51 M(+163.0%) | -$173.62 M(+71.9%) | -$196.51 M(+53.3%) |
| Sept 2020 | - | -$101.02 M(-391.7%) | -$128.16 M(+852.3%) |
| June 2020 | - | $34.64 M(-20.4%) | -$13.46 M(-73.5%) |
| Mar 2020 | - | $43.49 M(-141.3%) | -$50.86 M(-31.9%) |
| Dec 2019 | -$74.71 M(-1555.4%) | -$105.27 M(-869.4%) | -$74.71 M(-230.9%) |
| Sept 2019 | - | $13.68 M(-594.5%) | $57.07 M(+23.9%) |
| June 2019 | - | -$2.77 M(-114.1%) | $46.06 M(+892.5%) |
| Mar 2019 | - | $19.64 M(-25.9%) | $4.64 M(-9.6%) |
| Dec 2018 | $5.13 M(-107.8%) | $26.51 M(+890.2%) | $5.13 M(-45.3%) |
| Sept 2018 | - | $2.68 M(-106.1%) | $9.39 M(-79.8%) |
| June 2018 | - | -$44.19 M(-319.4%) | $46.37 M(-30.4%) |
| Mar 2018 | - | $20.14 M(-34.5%) | $66.61 M(-201.2%) |
| Dec 2017 | -$65.83 M(+26.4%) | $30.76 M(-22.4%) | -$65.83 M(-52.5%) |
| Sept 2017 | - | $39.66 M(-265.6%) | -$138.56 M(-15.6%) |
| June 2017 | - | -$23.95 M(-78.7%) | -$164.25 M(+13.9%) |
| Mar 2017 | - | -$112.30 M(+167.6%) | -$144.22 M(+176.9%) |
| Dec 2016 | -$52.08 M(-424.2%) | -$41.97 M(-400.4%) | -$52.08 M(-440.3%) |
| Sept 2016 | - | $13.97 M(-456.8%) | $15.30 M(+21.1%) |
| June 2016 | - | -$3.92 M(-80.6%) | $12.64 M(-54.8%) |
| Mar 2016 | - | -$20.16 M(-179.3%) | $28.00 M(+74.3%) |
| Dec 2015 | $16.06 M(-496.7%) | $25.41 M(+124.8%) | $16.06 M(-627.7%) |
| Sept 2015 | - | $11.31 M(-1.2%) | -$3.04 M(-28.9%) |
| June 2015 | - | $11.44 M(-135.6%) | -$4.28 M(-41.2%) |
| Mar 2015 | - | -$32.09 M(-609.1%) | -$7.28 M(+79.8%) |
| Dec 2014 | -$4.05 M | $6.30 M(-37.4%) | -$4.05 M(-10.8%) |
| Sept 2014 | - | $10.07 M(+19.3%) | -$4.54 M(-79.5%) |
| June 2014 | - | $8.44 M(-129.2%) | -$22.20 M(-45.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$28.86 M(-596.5%) | -$40.85 M(+2589.2%) |
| Dec 2013 | -$1.52 M(-94.7%) | $5.81 M(-176.6%) | -$1.52 M(+112.2%) |
| Sept 2013 | - | -$7.59 M(-25.6%) | -$716.00 K(-97.8%) |
| June 2013 | - | -$10.21 M(-197.5%) | -$32.10 M(+37.2%) |
| Mar 2013 | - | $10.47 M(+58.3%) | -$23.40 M(-18.8%) |
| Dec 2012 | -$28.82 M(-213.9%) | $6.62 M(-117.0%) | -$28.82 M(+8.2%) |
| Sept 2012 | - | -$38.97 M(+2482.8%) | -$26.64 M(-260.5%) |
| June 2012 | - | -$1.51 M(-129.9%) | $16.60 M(-13.9%) |
| Mar 2012 | - | $5.05 M(-42.5%) | $19.28 M(-23.8%) |
| Dec 2011 | $25.30 M(-26.1%) | $8.79 M(+106.2%) | $25.30 M(+221.9%) |
| Sept 2011 | - | $4.26 M(+263.9%) | $7.86 M(-70.2%) |
| June 2011 | - | $1.17 M(-89.4%) | $26.36 M(-35.1%) |
| Mar 2011 | - | $11.07 M(-228.0%) | $40.60 M(+18.6%) |
| Dec 2010 | $34.24 M(-164.0%) | -$8.65 M(-138.0%) | $34.24 M(-33.3%) |
| Sept 2010 | - | $22.76 M(+47.6%) | $51.36 M(-369.5%) |
| June 2010 | - | $15.42 M(+227.8%) | -$19.05 M(-60.7%) |
| Mar 2010 | - | $4.70 M(-44.5%) | -$48.53 M(-9.3%) |
| Dec 2009 | -$53.48 M(+436.6%) | $8.47 M(-117.8%) | -$53.48 M(-30.5%) |
| Sept 2009 | - | -$47.65 M(+239.0%) | -$77.00 M(+175.0%) |
| June 2009 | - | -$14.05 M(+5544.2%) | -$28.00 M(+99.6%) |
| Mar 2009 | - | -$249.00 K(-98.3%) | -$14.03 M(+40.7%) |
| Dec 2008 | -$9.97 M(-121.9%) | -$15.05 M(-1210.0%) | -$9.97 M(-138.4%) |
| Sept 2008 | - | $1.36 M(-1733.7%) | $25.95 M(+2.9%) |
| June 2008 | - | -$83.00 K(-102.2%) | $25.21 M(-45.6%) |
| Mar 2008 | - | $3.81 M(-81.7%) | $46.34 M(+1.9%) |
| Dec 2007 | $45.46 M(-432.3%) | $20.87 M(+3292.8%) | $45.46 M(-701.0%) |
| Sept 2007 | - | $615.00 K(-97.1%) | -$7.57 M(+40.6%) |
| June 2007 | - | $21.05 M(+618.2%) | -$5.38 M(-88.0%) |
| Mar 2007 | - | $2.93 M(-109.1%) | -$45.01 M(+229.0%) |
| Dec 2006 | -$13.68 M(-139.7%) | -$32.16 M(-1248.6%) | -$13.68 M(-156.1%) |
| Sept 2006 | - | $2.80 M(-115.1%) | $24.40 M(-21.2%) |
| June 2006 | - | -$18.58 M(-154.2%) | $30.98 M(-46.5%) |
| Mar 2006 | - | $34.26 M(+478.5%) | $57.89 M(+67.8%) |
| Dec 2005 | $34.49 M(-152.7%) | $5.92 M(-36.8%) | $34.49 M(+7.1%) |
| Sept 2005 | - | $9.38 M(+12.6%) | $32.20 M(-6.0%) |
| June 2005 | - | $8.33 M(-23.3%) | $34.24 M(-157.2%) |
| Mar 2005 | - | $10.86 M(+199.1%) | -$59.86 M(-8.6%) |
| Dec 2004 | -$65.51 M(+333.2%) | $3.63 M(-68.2%) | -$65.51 M(-5.3%) |
| Sept 2004 | - | $11.42 M(-113.3%) | -$69.14 M(-14.2%) |
| June 2004 | - | -$85.77 M(-1744.1%) | -$80.56 M(-1644.1%) |
| Mar 2004 | - | $5.22 M | $5.22 M |
| Dec 2003 | -$15.12 M(-167.0%) | - | - |
| Dec 2002 | $22.58 M | - | - |
FAQ
- What is Cytokinetics Incorporated annual cash flow from investing activities?
- What is the all time high annual CFI for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual CFI year-on-year change?
- What is Cytokinetics Incorporated quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly CFI year-on-year change?
- What is Cytokinetics Incorporated TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM CFI year-on-year change?
What is Cytokinetics Incorporated annual cash flow from investing activities?
The current annual CFI of CYTK is $239.25 M
What is the all time high annual CFI for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual cash flow from investing activities is $239.25 M
What is Cytokinetics Incorporated annual CFI year-on-year change?
Over the past year, CYTK annual cash flow from investing activities has changed by +$501.39 M (+191.27%)
What is Cytokinetics Incorporated quarterly cash flow from investing activities?
The current quarterly CFI of CYTK is -$45.05 M
What is the all time high quarterly CFI for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly cash flow from investing activities is $165.50 M
What is Cytokinetics Incorporated quarterly CFI year-on-year change?
Over the past year, CYTK quarterly cash flow from investing activities has changed by -$118.09 M (-161.68%)
What is Cytokinetics Incorporated TTM cash flow from investing activities?
The current TTM CFI of CYTK is -$745.37 M
What is the all time high TTM CFI for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM cash flow from investing activities is $349.91 M
What is Cytokinetics Incorporated TTM CFI year-on-year change?
Over the past year, CYTK TTM cash flow from investing activities has changed by -$1.10 B (-313.02%)